Literature DB >> 25873745

The appendix as a viable source of neural progenitor cells to functionally innervate bioengineered gastrointestinal smooth muscle tissues.

Elie Zakhem1, Stephen L Rego1, Shreya Raghavan1, Khalil N Bitar2.   

Abstract

UNLABELLED: Appendix-derived neural progenitor cells (NPCs) have both neurogenic and gliogenic potential, but use of these cells for enteric neural cell therapy has not been addressed. The objective of this study was to determine whether NPCs obtained from the appendix would differentiate into enteric neural subsets capable of inducing neurotransmitter-mediated smooth muscle cell (SMC) contraction and relaxation. NPCs were isolated from the appendix and small intestine (SI) of rabbits. Bioengineered internal anal sphincter constructs were developed using the same source of smooth muscle and innervated with NPCs derived from either the appendix or SI. Innervated constructs were assessed for neuronal differentiation markers through Western blots and immunohistochemistry, and functionality was assessed through force-generation studies. Expression of neural and glial differentiation markers was observed in constructs containing appendix- and SI-derived NPCs. The addition of acetylcholine to both appendix and SI constructs caused a robust contraction that was decreased by pretreatment with the neural inhibitor tetrodotoxin (TTX). Electrical field stimulation caused relaxation of constructs that was completely abolished in the presence of TTX and significantly reduced on pretreatment with nitric oxide synthase inhibitor (Nω-nitro-l-arginine methyl ester hydrochloride [l-NAME]). These data indicate that in the presence of identical soluble factors arising from intestinal SMCs, enteric NPCs derived from the appendix and SI differentiate in a similar manner and are capable of responding to physiological stimuli. This coculture paradigm could be used to explore the nature of the soluble factors derived from SMCs and NPCs in generating specific functional innervations. SIGNIFICANCE: This study demonstrates the ability of neural stem cells isolated from the appendix to differentiate into mature functional enteric neurons. The differentiation of neural stem cells from the appendix is similar to differentiation of neural stem cells derived from the gastrointestinal tract. The appendix is a vestigial organ that can be removed with minimal clinical consequence through laparoscopy. Results presented in this paper indicate that the appendix is a potential source of autologous neural stem cells required for cell therapy for the gastrointestinal tract. ©AlphaMed Press.

Entities:  

Keywords:  Appendix; Gastrointestinal; Neural differentiation; Neural progenitor cells; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 25873745      PMCID: PMC4449095          DOI: 10.5966/sctm.2014-0238

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  29 in total

1.  Neo-innervation of a bioengineered intestinal smooth muscle construct around chitosan scaffold.

Authors:  Elie Zakhem; Shreya Raghavan; Khalil N Bitar
Journal:  Biomaterials       Date:  2013-12-07       Impact factor: 12.479

2.  Enteric neural progenitors are more efficient than brain-derived progenitors at generating neurons in the colon.

Authors:  Quan Findlay; Kiryu K Yap; Annette J Bergner; Heather M Young; Lincon A Stamp
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-14       Impact factor: 4.052

3.  The influence of extracellular matrix composition on the differentiation of neuronal subtypes in tissue engineered innervated intestinal smooth muscle sheets.

Authors:  Shreya Raghavan; Khalil N Bitar
Journal:  Biomaterials       Date:  2014-06-11       Impact factor: 12.479

Review 4.  The enteric nervous system.

Authors:  M D Gershon
Journal:  Annu Rev Neurosci       Date:  1981       Impact factor: 12.449

5.  Reaggregation of rat dissociated myenteric plexus in extracellular matrix gels.

Authors:  K H Schäfer; P Mestres
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

6.  Bioengineering of physiologically functional intrinsically innervated human internal anal sphincter constructs.

Authors:  Robert R Gilmont; Shreya Raghavan; Sita Somara; Khalil N Bitar
Journal:  Tissue Eng Part A       Date:  2014-02-03       Impact factor: 3.845

7.  Perianal implantation of bioengineered human internal anal sphincter constructs intrinsically innervated with human neural progenitor cells.

Authors:  Shreya Raghavan; Eiichi A Miyasaka; Robert R Gilmont; Sita Somara; Daniel H Teitelbaum; Khalil N Bitar
Journal:  Surgery       Date:  2013-12-27       Impact factor: 3.982

8.  Multiple myenteric networks in the human appendix.

Authors:  Menachem Hanani
Journal:  Auton Neurosci       Date:  2004-01-30       Impact factor: 3.145

9.  Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia.

Authors:  R H Holloway; W J Dodds; J F Helm; W J Hogan; J Dent; R C Arndorfer
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

10.  Absence of NADPH-diaphorase activity in internal anal sphincter (IAS) achalasia.

Authors:  H Hirakawa; H Kobayashi; D S O'Briain; P Puri
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-01       Impact factor: 2.839

View more
  3 in total

Review 1.  Bioengineering and regeneration of gastrointestinal tissue: where are we now and what comes next?

Authors:  Elie Zakhem; Shreya Raghavan; Riley A Suhar; Khalil N Bitar
Journal:  Expert Opin Biol Ther       Date:  2019-03-26       Impact factor: 4.388

Review 2.  New approaches to increase intestinal length: Methods used for intestinal regeneration and bioengineering.

Authors:  Ali Shirafkan; Mauro Montalbano; Joshua McGuire; Cristiana Rastellini; Luca Cicalese
Journal:  World J Transplant       Date:  2016-03-24

Review 3.  Regenerative medicine provides alternative strategies for the treatment of anal incontinence.

Authors:  Søren Gräs; Cæcilie Krogsgaard Tolstrup; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2016-06-16       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.